연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
2107. The comprehensive complication index (CCI) is a more sensitive complication index than the conventional Clavien-Dindo classification in radical gastric cancer surgery.
Kim TH, Suh YS, Huh YJ, Son YG, Park JH, Yang JY, Kong SH, Ahn HS, Lee HJ, Slankamenac K, Clavien PA, Yang HK.
Gastric Cancer. 2018 Jan;21(1):171-181
Link
2106. Assessment of the Completeness of Lymph Node Dissection Using Near-infrared Imaging with Indocyanine Green in Laparoscopic Gastrectomy for Gastric Cancer.
Kim TH, Kong SH, Park JH, Son YG, Huh YJ, Suh YS, Lee HJ, Yang HK
J Gastric Cancer. 2018 Jun;18(2):161-171
Link
2105. Minimal-invasive gastrectomy: what the west can learn from the east?
Berlth F, Yang HK
Updates Surg. 2018 Jun;70(2):181-187
Link
2104. Clinical outcomes of intraoperative manual dilatation of pylorus in pylorus-preserving gastrectomy: a retrospective analysis.
Zhu CC, Kim TH, Berlth F, Park SH, Suh YS, Kong SH, Lee HJ, Cao H, Yang HK
Gastric Cancer. 2018 Sep;21(5):864-870
Link
2103. Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer.
Nam AR1, Kim JW2, Park JE1, Bang JH1, Jin MH1, Oh DY1,3, Bang YJ1,3.
Cancer Res Treat. 2018 Oct 1. doi: 10.4143/crt.2018.375. [Epub ahead of print]
Link
2102. Dynamics of Soluble Programmed Death-Ligand 1 (sPDL1) during Chemotherapy and its Prognostic Implications in Cancer Patients: Biomarker Development in Immuno-Oncology.
Ha H1, Bang JH2, Nam AR2, Park JE2, Jin MH2, Bang YJ1,2, Oh DY1,2.
Cancer Res Treat. 2018 Oct 5. doi: 10.4143/crt.2018.311. [Epub ahead of print]
Link
2101. Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer.
Nam AR1, Jin MH1, Park JE1, Bang JH1, Oh DY1,2, Bang YJ1,2.
Cancer Res Treat. 2018 Dec 3. doi: 10.4143/crt.2018.526. [Epub ahead of print]
Link
2100. Study design and early result of a phase I study of SABR for early-stage glottic cancer.
Yu T, Wee CW, Choi N, Wu HG, Kang HC, Park JM, Kim JI, Kim JH, Kwon TK, Chung EJ
Laryngoscope 2018 May 14 [Epub ahead of print]
Link
2099. Variability of gross tumor volume delineationfor stereotactic body radiotherapy of the lung with tri-60Co magnetic resonance image-guided radiotherapy system (ViewRay): A comparative study with magnetic resonance- and computed tomography-based target delineation.
Wee CW, An HJ, Kang HC, Kim HJ, Wu HG
Technology in Cancer Research & Treatment 2018;17:1-7
Link
2098. Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in rectal cancer treated with neoadjuvant concurrent chemoradiation: a meta-analysis and pooled-analysis of acute toxicity.
Wee CW1, Kang HC1, Wu HG1,2,3, Chie EK1,2,3, Choi N1, Park JM1,3, Kim JI1,3, Huang CM4, Wang JY5, Ng SY6, Goodman KA7,8.
Jpn J Clin Oncol. 2018 May 1;48(5):458-466. doi: 10.1093/jjco/hyy029.
Link